San Diego, California-based ResMed, maker of connected respiratory devices, announced strong results for its quarter ending on December 31, with over $530 million in revenue representing a 17 percent increase year over year.
On a call with investors, ResMed CEO Mick Farrell said the growth was driven by sales from Brightree – the cloud-based software company ResMed acquired last year for $800...
San Diego, California-based ResMed has received FDA 510(k) clearance for its small, portable continuous positive airway pressure (CPAP) device, the AirMini. The announcement was made during the JP Morgan conference in San Francisco today.
Designed to be used as an secondary device – particularly during travel or any other time the user doesn’t have access to or doesn’t want to bring their full-...
ResMed, a medical device company focused on sleep apnea, has launched its first consumer product, a $149 device for tracking and improving sleep called S+. The platform includes a non-contact, cellular-enabled device that uses a motion sensor to detect respiration and movement without touching the body, an app, and a cloud-based analytics engine.
"When we looked at the sleep market, what we...
